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Abstract
Background: Since its first publication, the Clinical Global Impression Scale (CGI) has become one of the most
widely used assessment instruments in psychiatry. Although some conflicting data has been presented, studies
investigating the CGI’s validity have only rarely been conducted so far. It is unclear whether the improvement
index CGI-I or a difference score of the severity index CGI-S dif is more valid in depicting clinical change. The
current study examined the validity of these two measures and investigated whether therapists’ CGI ratings
correspond to the view the patients themselves have on their condition.
Methods: Thirty-one inpatients of a German psychotherapeutic hospital suffering from a major depressive disorder
(age M = 45.3, SD = 17.2; 58.1% women) participated. Patients filled in the Beck Depression Inventory (BDI). CGI-S
and CGI-I were rated from three perspectives: the treating therapist (THER), the team of therapists involved in the
patient’s treatment (TEAM), and the patient (PAT). BDI and CGI-S were filled in at admission and discharge, CGI-I at
discharge only. Data was analysed using effect sizes, Spearman’s r and intra-class correlations (ICC).
Results: Effect sizes between CGI-I and CGI-S dif ratings were large for all three perspectives with substantially
higher change scores on CGI-I than on CGI-S dif. BDI dif correlated moderately with PAT ratings, but did not
correlate significantly with TEAM or THER ratings. Congruence between CGI-ratings from the three perspectives
was low for CGI-S dif (ICC = .37; Confidence Interval [CI] .15 to .59; F30,60 = 2.77, p < .001; mean r = 0.36) and
moderate for CGI-I (ICC = .65 (CI .47 to .80; F30,60 = 6.61, p < .001; mean r = 0.59).
Conclusions: Results do not suggest a definite recommendation for whether CGI-I or CGI-S dif should be used
since no strong evidence for the validity of neither of them could be found. As congruence between CGI ratings
from patients’ and staff’s perspective was not convincing it cannot be assumed that CGI THER or TEAM ratings fully
represent the view of the patient on the severity of his impairment. Thus, we advocate for the incorporation of
multiple self- and clinician-reported scales into the design of clinical trials in addition to CGI in order to gain
further insight into CGI’s relation to the patients’ perspective.
Background
The Clinical Global Impression Scale (CGI) is a brief
clinician-rated instrument that consists of three different
global measures. 1. Severity of illness: overall assessment
of the current severity of the patient’ss y m p t o m s( C G I -
S); 2. Global improvement: overall comparison of the
patient’s baseline condition with his current state (CGI-
I); 3. Efficacy index: overall comparison of the patient’s
baseline condition to a ratio of current therapeutic ben-
efit and severity of side effects (CGI-E). Since its first
publication the CGI has become one of the most widely
used assessment tools in psychiatry [1]. For example,
the CGI, especially the CGI improvement scale (CGI-I)
has been widely utilized as an efficacy measure in clini-
cal drug trials in different mental disorders [e.g., depres-
sion, schizophrenia; [2,3]]. Its popularity is mainly based
on its conciseness and easiness of administration.
It is widely accepted and some studies presented evi-
dence arguing that the CGI is a valid assessment instru-
ment. Moreover, the CGI was used as external criterion
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the Beck Depression Inventory [BDI; [4]], the Hamilton
Depression Rating Scale [HAMD; [5]] or the Montgom-
ery-Asberg Depression Rating Scale [MADRS; [6-9]].
Despite its general acceptance and extensive use as
outcome measure and criterion for the validation of
other instruments, the CGI’s psychometric characteris-
tics have only rarely been examined so far. Some evi-
dence has been presented arguing for its validity when
used in clinical trials [10]. Beyond that, in a recent
meta-analysis, Hedges et al. [11] calculated effect sizes
for CGI and other rating scales from 16 different studies
on social phobia and found mostly comparable effect
sizes for the CGI-I and several social anxiety scales. In
line with that, Khan et al. [12] found similar effect sizes
for MADRS, HAMD and CGI in antidepressant clinical
trials which were interpreted by the authors as support-
ing the CGI’s sensitivity.
H o w e v e r ,f r o me a r l yo n ,t h eC G Ih a sb e e nc r i t i c i z e d
for being inconsistent, unreliable and too general to
measure clinical conditions or treatment responses
validly [13,14]. Guy [15] draws attention on the role of
memory when using the CGI-I and claimed that the
task to compare a patient’s general clinical condition at
study end to that at the beginning of the study using
the CGI is essentially a test of the rater’s memory.
Recently, more empirical evidence for this criticism has
been presented. Busner et al. [16] found that the CGI
ratings of the clinicians are affected by indication-irrele-
vant adverse events reported by the patient. Participants
were asked to rate the severity of a major depressive dis-
o r d e ro rag e n e r a l i z e da n x i e ty disorder and nausea or
dizziness served as indication irrelevant medical events.
The more such events being reported by the patient, the
more likely the clinician rated the patient as more
severely ill. The authors concluded that these reports
can threaten validity of the CGI seriously. Jiang and
Ahmed [17] found evidence for relatively low correlation
between CGI-S and CGI-I which raised the question of
whether it is more appropriate to use the CGI-I or a dif-
ference between CGI-S pre and CGI-S post intervention
to judge change across treatment.
A couple of different efforts have been made to
improve the psychometric characteristics of the CGI.
Kadouri et al. [18] tested the use of a semi-structured
interview, a new response format and a Delphi process
to improve reliability of the CGI. Best results were
found when ratings of four different clinical raters were
averaged. Targum et al. [19] found significantly augmen-
ted scoring variance due to treatment emergent symp-
toms and developed targeted scoring criteria for the
CGI to enhance inter-rater reliability. Another attempt
to improve the CGI’s psychometric quality was the
development of alternative versions of the CGI for use
in special patient groups [e.g., [20]].
To sum up, results of studies on the psychometric
performance of the CGI are mixed. Additional research
appears necessary. More precisely, the question of
whether the CGI provides a valid measure of the
patient’s condition and if so whether it is more appro-
priate to use CGI-I or a difference score of CGI-S as
outcome criterion is not ultimately answered. The cur-
rent study therefore addressed this issue. First, we aimed
at clarifying whether the CGI provides a valid measure
of the patient’s condition. For this purpose, it was inves-
tigated whether CGI ratings correspond to the view the
patient has on his or her current condition. If so, clini-
cian rated CGI scores should relate to patient rated CGI
scores and scores on other patient reported outcome
measures. Furthermore - in correspondence with find-
ings from Kadouri et al. [18] - we expected that this
relation improves if not a single clinician does the rating
but a whole team of therapists using a consensus pro-
cess. Second, starting from the results of Jiang and
Ahmed [17] this study assessed whether it is valid to
rely on the CGI-I when rating clinical change or
whether calculating difference scores for CGI-S at the
beginning and the end of the intervention would
enhance validity. Based on Guy’s [15] notion on the role
of memory when using CGI-I we expected that differ-
ence scores for CGI-S were the more valid measure.
Implications for clinical practice will be discussed.
Methods
Sample
The sample consisted of 31 inpatients of a German psy-
chotherapeutic hospital suffering from a major depres-
sive disorder (MDD) according to the criteria of the
10
th edition of the International Classification of Dis-
eases (ICD-10). Diagnoses were verified in a two step
procedure: First, depression was assessed by the treating
therapist using a clinical interview in which the Interna-
tional Diagnostic Checklist for depression (IDCL) [21]
was applied. The IDCL is a checklist that can be used to
make a careful evaluation of the symptoms and classifi-
cation criteria, and thus help to arrive at precise diag-
noses according to ICD-10 criteria for a depressive
episode. If the therapist was still unsure about the diag-
nosis after using IDCL, the German Version of the
Structured Clinical Interview for DSM-IV (SKID) [22]
was conducted in addition. The clinical interviews were
conducted by clinical psychologists. In the second step,
diagnoses were verified through clinical conferences
including senior psychotherapists and psychiatrists.
Mean age of patients was 45.3 years (SD = 17.2), 58.1%
were women. Patients stayed at hospital for 41 days
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ple, it reflected all “facets”, levels, and stages of chroni-
city of depression. All participants took part voluntarily
w i t h o u tp a y m e n ta n ds i g n e da ni n f o r m e dc o n s e n tp r i o r
to testing. The study procedures were in accordance
with the declaration of Helsinki and approved by the
local ethics committee of the Medical Faculty of the
RWTH Aachen University (EK 172/05). See table 1 for
sample details.
At the hospital, patients are treated on an inpatient
basis with high-density empirically-based psychother-
apy that is personalized depending on the disorder of
the patient. The program uses symptom-focused and
highly individualized interventions. Each inpatient is
treated by only one therapist for as long as eight hours
per day.
High-density psychotherapy typically includes four
phases: (1) Psychological assessment and a medical
examination from which feedback is given to the
patient, as is information about the therapy program.
This phase includes 6-8 sessions, and it lasts one or two
days. (2) Cognitive preparation for therapy is given to
enhance the patient’s motivation for specific treatment
exercises. The patient’s core assumptions about the
aetiology of his or her disorder are taken into account
when the treatment plan is devised. The therapist
explains to the patient the details of the therapy and the
subsequent steps to be taken. (3) During this phase, spe-
cific therapeutic exercises are carried out. These include
standard elements of cognitive behavioural therapy for
depression. (4) The self-management phase begins after
several days of high-density psychotherapy. At the
beginning of this phase, the therapist helps the patient
to plan and organize the tasks to be undertaken; there-
after, the patient is asked to independently devise diffi-
cult tasks to do. Finally, the difficulties that the patient
h a si nc o m p l e t i n gt h et a s k sa re evaluated. After dis-
charge, therapists remain in telephone contact with their
patients for at least six weeks.
Material
Beck Depression Inventory (BDI)
The BDI contains 21 items [4]. Each item consists of
four self-referring statements (e.g. “Ia ms a d ”). Item
scores range from 0 to 3 and participants are supposed
to choose one or more statements per item that repre-
sents best their mental state during the last week. A
total score >10 indicates mild to moderate depression
and a total score >18 moderate to severe depression.
The BDI was filled in at admission and discharge.
Clinical Global Impression Scale (CGI)
The CGI consists of three global measures. The CGI
severity of illness measure (CGI-S) is rated from 1 (nor-
mal, not at all ill) to 7 (among the most extremely ill
patients). A “0” is allocated if the patient was not
assessed. The CGI-S was rated at admission (CGI-Sadm)
a n da td i s c h a r g e( C G I - Sdis). The CGI global improve-
ment measure (CGI-I) is rated from 1 (very much
improved) to 7 (very much worse). Again, “0” stands for
“not assessed”. The CGI-I was rated at discharge only.
The third measure is called the efficacy index CGI-E. It
was not assessed in the current study [1].
The CGI measures were rated from three perspectives:
the treating therapist (THER), the team of therapists
concerned with the patient (TEAM), and the patient
him- or herself (PAT). The team of therapists concerned
with the patient performed a delphi process to reach a
consensus rating of the respective patient’s condition.
Data analysis
CGI-I vs. CGI-S dif
Difference scores for CGI-S (CGI-S dif = CGI-Sadm-CGI-
S dis) were determined and contrasted to CGI-I ratings
for all three perspectives to determine congruence of
the two global ratings. Additionally, effect sizes d
between CGI-S dif and CGI-I and their confidence inter-
vals (95%) were calculated for all three perspectives. If
t h ec o n f i d e n c ei n t e r v a lf o rt h eE Si n c l u d e sz e r o ,t h e
effect can be regarded as statistically nonsignificant. In
order to reduce sampling error effect sizes have been
corrected using a factor provided by Hedges and Olkin
[23]. Following Cohen [24] effect sizes .20 <d ≤ .50 were
interpreted as small, .50 <d ≤ .80 as medium, and d ≥
.80 as large. Before calculating effect sizes, CGI-S dif was
rescaled for this step of analysis into values from 1 to 7
with 4 meaning no change in order to bring CGI-I and
CGI-S dif to a common metric. Above, both CGI-I and
CGI-S dif were correlated (Spearman’s r)w i t hB D Id i f -
ference scores (BDI dif = BDIadm-BDI dis).
Congruence between patients’, therapists’ and teams’
perspectives on CGI-S and CGI-I
Means and standard deviations (SD) for CGI-Sadm, CGI-
S dis and for CGI-I were calculated. Corrected effect
sizes d were calculated between CGI-Sadm and CGI-S dis
Table 1 Sample details
MS D
Age 45.3 17.2
N%
Gender (female) 18 58.1
Comorbidity
F1x.xx 4 12.9
F4x.xx 10 32.3
F5x.xx 4 12.9
F6x.xx 7 22.6
F9x.xx 1 3.2
No comorbidity 5 16.1
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gruency between the three perspectives were calculated.
Because interval scale level of data collected with the
CGI could not be taken for granted we decided to
report both measures for interval scale level data and
measures for ordinal scale level data. As measures of
congruency for interval scale level data intraclass corre-
lations (ICC) according to McGraw and Wong [25]
were calculated separately for CGI-Sadm,C G I - Sdis,a n d
CGI-I to determine congruency of the patients’,t h e r a -
pists’ and team’s ratings on these three global measures.
In addition, Spearman’s r for ordinal scale level data
was determined. Significance level was set at a = .05.
All analyses were conducted using SPSS 17 for
Windows.
Results
CGI-I vs. CGI-S dif
On average, patients, therapists and teams rated the
patient’s condition on CGI-I with a “2” indicating
“much improvement” [1] (see table 2). By contrast, the
rescaled difference values between CGI-Sadm and CGI-S
dis revealed an averaged improvement of 3.55 (SD =
0.57). A value of “4” indicates no change. Effect sizes
between CGI-I and CGI-S dif ratings were large for all
three perspectives (see figure 1) with substantially higher
change scores on CGI-I than on CGI-S dif. Correlations
(Spearman’s r)w i t hB D Idif were rBDIdif/CGI-I-PAT =- . 3 9
(p = .02), rBDIdif/CGI-I-THER = -.16 (p = .34), rBDIdif/CGI-I-
TEAM =- . 2 3( p=. 1 6 ) ,rBDIdif/CGI-S-dif-PAT =. 2 9( p=
.07), rBDIdif/CGI-S-dif-THER = .24 (p = .13) and rBDIdif/CGI-
S-dif-TEAM = -.08 (p = .60). Thus, results suggest that
BDIdif correlated moderately with ratings from the
patients’ perspective, but did not correlate significantly
with ratings from the therapists’ or teams’ perspective.
Correlations with BDI dif thus differed between perspec-
tives but not between CGI-I and CGI-S dif.
Congruence between patients’, therapists’ and teams’
perspectives on CGI-S and CGI-I
Mean CGI-Sadm ratings at admission were 4.0 (SD = 1.9)
for the patient, 4.97 (SD = 0.71) for the therapist, and
5.0 (SD = 0.63) for the team perspective. At discharge
all mean ratings dropped: patients’ CGI-S dis mean rat-
ings were 3.45 (SD = 1.50), therapists’ were 3.87 (SD =
1.09), and teams’ ratings were 3.94 (SD = 0.77). The
resulting effect sizes d differed substantially (dPatient =
.32; dtherapist = 1.18; dteam = 1.48). The effect size for the
patient perspective was markedly smaller than for the
other two perspectives which coincided with a much
bigger standard deviation. Effect size for BDI sum scores
was large (dBDI = 1.15; Madm = 20.2, SDadm =8 . 4 ;
Mdis = 10.7, SDdis = 7.9).
CGI-Sadm (ICC = .22; Confidence Interval [CI] .00 to
.46; F30,60 =1 . 8 2 ,p = .02; mean r =0 . 2 9 )a n dC G I - Sdis
(ICC = .24; CI .03 to .48; F 30,60 =1 . 9 7 ,p =. 0 1 ;m e a nr
=0 . 5 9 )r a t i n g sa sw e l la st h ed i f f e r e n c e sC G I - Sdif
between both (ICC = .37; CI .15 to .59; F30,60 = 2.77, p
< .001; mean r = 0.36) showed low ICCs indicating low
congruency of ratings between the three perspectives. In
all three cases, the ratings from the patient’s perspective
showed substantially lower intercorrelations with the
ratings from the other two perspectives (see table 3).
Mean CGI-I ratings were 2.03 (SD = 1.20) for the
patient, 2.16 (SD = .82) for the therapist and 2.10 (SD =
.91) for the team perspective. The intraclasscorrelation
between the patients’,t h e r a p i s t s ’ and team’sr a t i n g so n
CGI-I was ICC = .65 (CI .47 to .80; F30,60 = 6.61, p <
Table 2 Mean ratings on CGI-I and CGI-S at admission
and discharge from all three perspectives
admission discharge difference effect size
M SD M SD M SD d Lower
CI
Upper
CI
CGI-S
patient
4.00 1.90 3.45 1.50 .55 1.18 0.32 -0.18 0.82
CGI-S
therapist
4.97 0.71 3.87 1.09 1.10 1.14 1.18 0.64 1.72
CGI-S
team
5.00 0.63 3.94 0.77 1.10 1.09 1.48 0.92 2.05
BDI 20.24 8.41 10.68 7.88 9.56 9.09 1.15 0.56 1.75
CGI-I
patient
–– 2.03 1.20 ––– – –
CGI-I
therapist
–– 2.16 .82 ––– – –
CGI-I
team
–– 2.10 .91 ––– – –
Effect sizes of the differences between admission and discharge are corrected
according to Hedges and Olkin [21].
Figure 1 Effect sizes between CGI-I and CGI-Sdif for the
perspectives patient (PAT), therapist (THER) and team of
therapists concerned with the patient (TEAM). Higher scores
indicate greater change between admission and discharge.
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ment between the ratings from the three perspectives.
Discussion
T h ec u r r e n ts t u d ya i m e da ti n vestigating the validity of
the CGI-I and CGI-S dif as outcome measures in clinical
trials. More precisely, it was examined whether use of
CGI-I or CGI-S dif appears more appropriate. Above, it
was investigated whether therapists’ CGI ratings corre-
spond to the view the patients themselves have on their
condition.
The results of the present study showed that CGI-I
provided relatively high change scores compared to the
difference score CGI-S dif in terms of effect sizes. To rate
a patient’s condition on the CGI-I clinicians first have to
remember the patient’s condition at admission and then
contrast it to their condition at present. By contrast,
CGI-S only needs representation of the patient’s current
condition. Thus, the current results might be interpreted
as suggesting that using CGI-I might be more prone to
well known effects of hindsight memory distortion [e.g.,
[26]]: When using CGI-I at discharge, therapists, teams
and patients might have been inclined to retrospectively
recall the patient’s condition at admission as more
impaired than it really was according to CGI-Sadm and
thus rated change of condition as more prominent. If this
was the case, in our view, it would threaten the validity
of CGI-I as outcome measure in clinical trials. However,
additional research is needed directly addressing the role
of memory effects on results in CGI-I until a definite
conclusion on this issue is possible.
The congruence of ratings from the three perspectives
on CGI-I was moderate to good and much better than
the congruence of ratings on CGI-S. Moreover, while
congruence between the single therapists and the teams
was moderate to good, patients gave divergent ratings
especially on CGI-S dif. Overall, patients provided the
most conservative ratings for change, in both CGI-I and
CGI-S dif. Simultaneously, patients’ ratings correlated
most strongly with BDI dif for both CGI-I and CGI-S dif
while correlations with BDI for the other two perspec-
tives were virtually zero. One might oppose that doubts
on the validity of a self-reported CGI-rating might be
warrantable because originally the CGI was not desig-
nated to be a self-rated scale so that low correlations
with self-reported CGI could be seen as weak criterion
for validity. However, self-reported CGI-ratings corre-
lated significantly with BDI and the validity of BDI as an
instrument for the assessment of depression severity has
been shown in numerous studies [for some recent
examples see e.g., [27,28]]. These results suggest that
CGI ratings - regardless of whether CGI-I or CGI-S dif
are concerned - made by the treating therapist or
obtained through a consensus process in the team of
therapists appear not to fully represent the view of the
patient on the severity of his or her impairment.
So which global measure of CGI should be used as
outcome measure, CGI-I or CGI-S dif?R e s u l t so ft h e
present study do not suggest a definite recommendation
since no strong evidence for the validity of neither CGI-
In o rC G I - Sdif could be found. In our view, the overall
picture of results could be interpreted as being slightly
in favour for CGI-I but without doubt additional
research is needed.
As already noted, there were no substantial differences
between therapists’ and teams’ ratings. One potential
explanation is that in our study the therapist who did
the single rating was also member of the team of thera-
pists and might have influenced the consensus rating in
his favoured direction. Nevertheless, at least under the
conditions described, our results suggest that in contrast
to Kadouri et al. [18] a consensus rating following a
Delphi process does not necessarily change reliability or
validity of the rating.
Ac o u p l eo fl i m i t a t i o n so ft h ec u r r e n ts t u d yh a v et o
be reported. The sample size was rather small so that
reported results should be interpreted with care.
Above, only patients suffering from a MDD have been
assessed which impedes generalizability of the reported
results to other patient groups. Because the length of
the current depressive episode could not be determined
from study data, it could not be ruled out that length
of depressive episode or chronicity could have had an
influence on results. Furthermore, since neither the
Table 3 Intercorrelations between the three perspectives for CGI-I, CGI-Sadm, CGI-Sdis, and CGI-Sdif
CGI-I CGI-Sadm CGI-Sdis CGI-Sdif
patient therapist team patient therapist team patient therapist team patient therapist team
Patient CGI-
I
1.00 CGI-S
adm
1.00 CGI-
S
dis
1.00 CGI-
S
dif
1.00
therapist 0.51 1.00 0.30 1.00 0.27 1.00 0.29 1.00
team 0.53 0.73 1.00 0.20 0.78 1.00 0.08 0.54 1.00 0.20 0.58 1.00
M 0.42 0.29 0.59 0.36
Note. M = mean; correlations in italics are significant at a = .05.
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ple of the adult population the rather low to moderate
ICC found in the present study might simply be
explained by the fact that only a very homogeneous
sample consisting of patients who had been hospita-
lized for MDD has been investigated. Replication stu-
dies, ideally with larger and more heterogeneous
samples are warranted.
The only criterion available for the validation of the
CGI in this study was self-reported data (BDI and
patients’ ratings on CGI). However, the most valid pro-
cedure for diagnosing a depressive disorder is a struc-
tured diagnostic interview based on DSM-IV [29] or
ICD-10 [30] criteria that is conducted by a clinical
expert. Thus, future studies should incorporate inter-
view-based assessments at discharge for replication of
the present findings.
The reported findings were not collected in a clinical
trial which is one of the main areas of application for
CGI. In clinical trials clinicians are usually blinded as to
what study condition the patient belongs, e.g., treatment
vs. placebo. Thus, they do not know whether it is sup-
portive for the aim of the study to state that the patient
improved much or not. However, in this study, clini-
cians treated and rated the patients themselves. It might
therefore be possible that clinicians might have been
inclined to assign relatively high change scores. How-
ever, they also knew that the conducted study did not
aim at evaluating therapy effects so that we expect the
effect of such demand characteristics in our data to be
rather small. Nevertheless, future research should inves-
tigate whether our results could be replicated in a
blinded setting.
Conclusions
In summary, in line with previous research [16,17,19]
the results of the present study cast doubt on the
validity of the CGI. To our knowledge, this is the first
study that included correspondence of clinician rated
CGI scores with the patients’ own perspective on their
clinical condition as one criterion of validity. Our
results do not suggest a definite recommendation for
whether CGI-I or CGI-S dif should be used since no
strong evidence for the validity of neither CGI-I nor
CGI-S dif in terms of high correlations with ratings
from the patients’ perspective could be found. We
conclude that it cannot be recommended to rely upon
CGI alone as outcome measure in clinical trials
but rather advocate for the incorporation of multiple
self- and clinician-reported scales into the design of
clinical trials in addition to CGI in order to gain
further insight into CGI’s relation to the patients’
perspective.
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